Boston Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,415
Closed -$406K 766
2024
Q4
$406K Sell
18,415
-93,117
-83% -$2.05M ﹤0.01% 661
2024
Q3
$2.01M Buy
111,532
+55,252
+98% +$996K ﹤0.01% 511
2024
Q2
$915K Buy
56,280
+27,224
+94% +$442K ﹤0.01% 596
2024
Q1
$410K Sell
29,056
-191,202
-87% -$2.7M ﹤0.01% 718
2023
Q4
$587K Buy
+220,258
New +$587K ﹤0.01% 595
2019
Q1
Sell
-176,478
Closed -$2.72M 723
2018
Q4
$2.72M Buy
+176,478
New +$2.72M ﹤0.01% 497
2017
Q3
Sell
-141,852
Closed -$4.71M 781
2017
Q2
$4.71M Buy
141,852
+34,846
+33% +$1.16M 0.01% 484
2017
Q1
$3.43M Sell
107,006
-1,497,174
-93% -$48M ﹤0.01% 566
2016
Q4
$58.2M Sell
1,604,180
-363,872
-18% -$13.2M 0.08% 212
2016
Q3
$90.6M Sell
1,968,052
-48,848
-2% -$2.25M 0.13% 184
2016
Q2
$101M Sell
2,016,900
-2,501,491
-55% -$126M 0.15% 179
2016
Q1
$242M Buy
4,518,391
+794,272
+21% +$42.5M 0.36% 98
2015
Q4
$244M Sell
3,724,119
-1,279,172
-26% -$84M 0.35% 92
2015
Q3
$282M Sell
5,003,291
-3,752,147
-43% -$212M 0.43% 66
2015
Q2
$517M Sell
8,755,438
-238,262
-3% -$14.1M 0.74% 37
2015
Q1
$560M Sell
8,993,700
-206,302
-2% -$12.9M 0.83% 32
2014
Q4
$529M Buy
9,200,002
+1,408,944
+18% +$81M 0.79% 33
2014
Q3
$419M Buy
7,791,058
+4,887,106
+168% +$263M 0.68% 41
2014
Q2
$152M Buy
2,903,952
+2,789,891
+2,446% +$146M 0.25% 109
2014
Q1
$6.03M Sell
114,061
-11,631
-9% -$615K 0.01% 488
2013
Q4
$5.04M Hold
125,692
0.01% 509
2013
Q3
$4.75M Sell
125,692
-89,456
-42% -$3.38M 0.01% 499
2013
Q2
$8.43M Buy
+215,148
New +$8.43M 0.02% 372